1: Mu Q, Yao K, Syeda MZ, Zhang M, Cheng Q, Zhang Y, Sun R, Lu Y, Zhang H, Luo Z, Huang H, Liu X, Luo C, Zhu X, Wu S, Cui L, Huang C, Chen X, Tang L. Ligustrazine Nanoparticle Hitchhiking on Neutrophils for Enhanced Therapy of Cerebral Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2023 Jul;10(19):e2301348. doi: 10.1002/advs.202301348. Epub 2023 Apr 20. PMID: 37078794; PMCID: PMC10323616.
2: Jiang X, Li S, Wang N, Li J. Ligustrazine as a multitarget scaffold in drug design and discovery. Bioorg Med Chem. 2025 Apr 15;121:118110. doi: 10.1016/j.bmc.2025.118110. Epub 2025 Feb 11. PMID: 39955802.
3: Gao HJ, Liu PF, Li PW, Huang ZY, Yu FB, Lei T, Chen Y, Cheng Y, Mu QC, Huang HY. Ligustrazine monomer against cerebral ischemia/reperfusion injury. Neural Regen Res. 2015 May;10(5):832-40. doi: 10.4103/1673-5374.156991. PMID: 26109963; PMCID: PMC4468780.
4: Chen X, Yang T, Zhou Y, Mei Z, Zhang W. Astragaloside IV combined with ligustrazine ameliorates abnormal mitochondrial dynamics via Drp1 SUMO/deSUMOylation in cerebral ischemia-reperfusion injury. CNS Neurosci Ther. 2024 Apr;30(4):e14725. doi: 10.1111/cns.14725. PMID: 38615367; PMCID: PMC11016344.
5: Zhang Q, Wang J, Zhu L, Jiang SJ, Liu J, Wang LX, Qin XH. Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats. Curr Med Sci. 2021 Jun;41(3):548-554. doi: 10.1007/s11596-021-2379-1. Epub 2021 Jun 25. PMID: 34169425.
6: Wen Y, Zhang Z, Cai Z, Liu B, Wu Z, Liu Y. Ligustrazine-Loaded Borneol Liposome Alleviates Cerebral Ischemia-Reperfusion Injury in Rats. ACS Biomater Sci Eng. 2022 Nov 14;8(11):4930-4941. doi: 10.1021/acsbiomaterials.2c00847. Epub 2022 Oct 13. PMID: 36227861.
7: Yang H, Xu G, Li Q, Zhu L. Ligustrazine alleviates the progression of coronary artery calcification by inhibiting caspase-3/GSDME mediated pyroptosis. Biosci Trends. 2024 Nov 15;18(5):482-491. doi: 10.5582/bst.2024.01096. Epub 2024 Jul 6. PMID: 38972749.
8: Ji R, Gan Q, Shu X, Xu R, Huang X, Shen T. The efficacy of Salvia- ligustrazine and Ligustrazine in treating gestational hypertension: A systematic review and meta-analysis. Biomol Biomed. 2024 Oct 17;24(6):1517-1534. doi: 10.17305/bb.2024.10743. PMID: 39115338; PMCID: PMC11496844.
9: Qiu JL, Zhang GF, Chai YN, Han XY, Zheng HT, Li XF, Duan F, Chen LY. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-β/Smad Signaling in an Animal Model of Biliary Atresia. J Pharmacol Exp Ther. 2022 Jun;381(3):257-265. doi: 10.1124/jpet.121.001020. Epub 2022 Apr 9. PMID: 35398813.
10: Yuan Y, Zhao L, Wang X, Lian F, Cai Y. Ligustrazine-induced microRNA-16-5p inhibition alleviates preeclampsia through IGF-2. Reproduction. 2020 Dec;160(6):905-917. doi: 10.1530/REP-20-0309. PMID: 33112793.
11: Chen Y, Xing Z, Chen J, Sun C, Liu Y, Peng C, Peng F, Li D. SIRT1 activation by Ligustrazine ameliorates migraine via the paracrine interaction of microglia and neurons. Phytomedicine. 2024 Dec;135:156069. doi: 10.1016/j.phymed.2024.156069. Epub 2024 Sep 17. PMID: 39341123.
12: Shao H, Zhao L, Chen F, Zeng S, Liu S, Li J. Efficacy of Ligustrazine Injection as Adjunctive Therapy for Angina Pectoris: A Systematic Review and Meta-Analysis. Med Sci Monit. 2015 Nov 29;21:3704-15. doi: 10.12659/msm.895362. PMID: 26615387; PMCID: PMC4671452.
13: Li H, Yang M. Ligustrazine activate the PPAR-γ pathway and play a protective role in vascular calcification. Vascular. 2022 Dec;30(6):1224-1231. doi: 10.1177/17085381211051477. Epub 2021 Oct 20. PMID: 34670463.
14: Feng Y, Dong H, Zheng L. Ligustrazine inhibits inflammatory response of human endometrial stromal cells through the STAT3/IGF2BP1/RELA axis. Pharm Biol. 2023 Dec;61(1):666-673. doi: 10.1080/13880209.2023.2195883. PMID: 37095705; PMCID: PMC10132247.
15: Chen RJ, Chen MC, Tsai BC, Roy R, Chang YR, Wang TF, Kuo WW, Kuo CH, Yao CH, Li CC, Huang CY. Ligustrazine improves the compensative effect of Akt survival signaling to protect liver Kupffer cells in trauma-hemorrhagic shock rats. Chem Biol Drug Des. 2023 Dec;102(6):1399-1408. doi: 10.1111/cbdd.14327. Epub 2023 Aug 23. PMID: 37612133.
16: Wang Y, Zhu H, Tong J, Li Z. Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma. Comput Math Methods Med. 2022 Jan 10;2022:1452116. doi: 10.1155/2022/1452116. PMID: 35047052; PMCID: PMC8763486.
17: Lian N, Tong J, Zhu W, Meng Q, Jiang M, Bian M, Li Y. Ligustrazine and liguzinediol protect against doxorubicin-induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy. Clin Exp Pharmacol Physiol. 2023 Nov;50(11):867-877. doi: 10.1111/1440-1681.13811. Epub 2023 Aug 13. PMID: 37574718.
18: Jiang G, Xin R, Yuan W, Zhang L, Meng X, Sun W, Han H, Hou Y, Wang L, Du P. Ligustrazine ameliorates acute kidney injury through downregulation of NOD2‑mediated inflammation. Int J Mol Med. 2020 Mar;45(3):731-742. doi: 10.3892/ijmm.2020.4464. Epub 2020 Jan 10. PMID: 31985025; PMCID: PMC7015130.
19: Li L, Chen H, Shen A, Li Q, Chen Y, Chu J, Liu L, Peng J, Chen K. Ligustrazine inhibits platelet activation via suppression of the Akt pathway. Int J Mol Med. 2019 Jan;43(1):575-582. doi: 10.3892/ijmm.2018.3970. Epub 2018 Nov 1. PMID: 30387814.
20: Zou J, Gao P, Hao X, Xu H, Zhan P, Liu X. Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives. Eur J Med Chem. 2018 Mar 10;147:150-162. doi: 10.1016/j.ejmech.2018.01.097. Epub 2018 Feb 5. PMID: 29432947.